MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Pfizer

Open

BrancheGesundheitswesen

22.79 0.4

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

22.5

Max

22.85

Schlüsselkennzahlen

By Trading Economics

Einkommen

-4.1B

411M

Verkäufe

63M

18B

KGV

Branchendurchschnitt

15.631

57.333

EPS

0.63

Dividendenrendite

7.8

Gewinnspanne

2.314

Angestellte

81,000

EBITDA

-4.3B

2.5B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+22.04% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

7.80%

2.63%

Nächstes Ergebnis

29. Apr. 2025

Nächste Dividendenausschüttung

13. Juni 2025

Nächstes Ex-Dividendendatum

9. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-26B

126B

Vorheriger Eröffnungskurs

22.39

Vorheriger Schlusskurs

22.79

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Pfizer Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Apr. 2025, 11:09 UTC

Wichtige Markttreiber

Pfizer Shares Slip After Company Scraps Weight-Loss Pill

9. Apr. 2025, 18:18 UTC

Wichtige Markttreiber

Pharma Shares Reverse Losses After Tariff Pause

9. Apr. 2025, 09:39 UTC

Wichtige Markttreiber

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

19. März 2025, 07:34 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18. März 2025, 17:26 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer to Dispose of Remaining Shareholding in Haleon

14. Apr. 2025, 14:36 UTC

Top News

Pfizer Halts Development of Weight-Loss Pill -- Update

14. Apr. 2025, 14:14 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Viking Seen as Potential Ticket To Get Pfizer Back Into Obesity Game -- Market Talk

14. Apr. 2025, 10:45 UTC

Top News

Pfizer Halts Development of Weight-Loss Pill -- WSJ

8. Apr. 2025, 21:26 UTC

Ergebnisse

Pfizer Stock's Fall to '97 Level Lifts Yield Near 8%. Dividend Looks Safe. -- Barrons.com

26. März 2025, 22:29 UTC

Top News

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- 2nd Update

26. März 2025, 19:19 UTC

Top News

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- Update

26. März 2025, 17:39 UTC

Top News

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine -- WSJ

18. März 2025, 16:58 UTC

Akquisitionen, Fusionen, Übernahmen

Haleon Intends to Cancel Purchased Ordinary Shares

18. März 2025, 16:57 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18. März 2025, 16:56 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18. März 2025, 16:56 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18. März 2025, 16:52 UTC

Akquisitionen, Fusionen, Übernahmen

Haleon Takes Note of Announcement

18. März 2025, 16:50 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18. März 2025, 16:50 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: This Is Subject to Customary Closing Conditions

18. März 2025, 16:50 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18. März 2025, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18. März 2025, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Bookbuilding Period Will Commence Immediately

18. März 2025, 16:49 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18. März 2025, 16:48 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

18. März 2025, 16:47 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

18. März 2025, 16:47 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: This Represents Approx 7.3% Stake in Haleon

18. März 2025, 16:46 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

17. März 2025, 09:00 UTC

Top News

Pfizer Has a New Playbook for Reviving Sales -- And It's Starting to Pay Off -- WSJ

28. Feb. 2025, 12:00 UTC

Top News

Drug Stocks Are the New Safe Bet in a Shaky Market -- Heard on the Street -- WSJ

14. Feb. 2025, 11:38 UTC

Top News
Ergebnisse

Moderna's Results Reaffirm a Grim Picture for Vaccine Maker -- Barrons.com

Peer-Vergleich

Kursveränderung

Pfizer Prognose

Kursziel

By TipRanks

22.04% Vorteil

12-Monats-Prognose

Durchschnitt 27.8 USD  22.04%

Hoch 32 USD

Tief 23 USD

Basierend auf 17 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pfizer – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

17 ratings

5

Buy

12

Halten

0

Sell

Technischer Score

By Trading Central

22.12 / 23.055Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Very Strong Bearish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.